Floridian Research Institute

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa3 trials
• Epilepsy1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Biohaven Therapeutics Ltd.1 trial
• Navigator Medicines, Inc.1 trial

Running trials

• Recruiting

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Luis Javier Arechavaleta

• Recruiting

  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  NCT07384975· Phase 2· Navigator Medicines, Inc.· Source

  Contact: Associate Director, Clinical Operations

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06840392· Phase 3· Novartis Pharmaceuticals· Source

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa2 recruiting
• Epilepsy1 recruiting